Biologie et Pharmacologie des Plaquettes Sanguines : hémostase, thrombose, transfusion - BPPS - UMRS1255

  • Flux RSS
(1 - 20 of 741)

Pages

Export to file
Bookmark
Étiquette
A 13 base pair deletion in the GPIbbeta gene in a second unrelated Bernard-Soulier family due to slipped mispairing between direct repeats.
STRASSEL, C., ALESSI, M. C., JUHAN-VAGUE, I., CAZENAVE, J. P. et LANZA, F., 2004. A 13 base pair deletion in the GPIbbeta gene in a second unrelated Bernard-Soulier family due to slipped mispairing between direct repeats. Journal of Thrombosis and Haemostasis [en ligne]. 2004. Vol. 2, n° 9pp. 1663-1665. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=153330451. 506.
A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques
REININGER, A. J., BERNLOCHNER, I., PENZ, S. M., RAVANAT, C., SMETHURST, P., FARNDALE, R. W., GACHET, C., BRANDL, R. et SIESS, W., 2010. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. Journal of the American College of Cardiology. 2010. Vol. 55, n° 11pp. 1147-1158.
Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation
ECKLY, A., STRASSEL, C., FREUND, M., CAZENAVE, J. P., LANZA, F., GACHET, C. et LEON, C., 2009. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood [en ligne]. 2009. Vol. 113, pp. 3182-3189. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18984861
Abrégé de Médecine Transfusionnelle.
WALLER, C., FOLLEA, G., CAZENAVE, J. P., FARADJI, A. et BELLER, J. P., 1995. Abrégé de Médecine Transfusionnelle. book. Strasbourg : Etablissement de Transfusion Sanguine de Strasbourg. 1. 332.
Accroître la sécurité transfusionnelle en l'an 2000.
CAZENAVE, J. P., 1999. Accroître la sécurité transfusionnelle en l'an 2000. Impressions. Journal des Hôpitaux Universitaires de Strasbourg. 1999. Vol. 68. 1. 428.
Activation of ADP receptors and platelet function.
GACHET, C., HECHLER, B., LEON, C., VIAL, C., LERAY, C., OHLMANN, P. et CAZENAVE, J. P., 1997. Activation of ADP receptors and platelet function. Thrombosis and Haemostasis [en ligne]. 1997. Vol. 78, n° 1pp. 271-275. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=91981651. 365.
Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.
FREYSSINET, J. M., WIESEL, M. L., GRUNEBAUM, L., PEREILLO, J. M., GAUCHY, J., SCHUHLER, S., FREUND, G. et CAZENAVE, J. P., 1989. Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides. Biochemical Jourmal [en ligne]. 1989. Vol. 261, n° 2pp. 341-348. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24761151. 198.
Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia.
KOUNS, W. C., STEINER, B., KUNICKI, T. J., MOOG, S., JUTZI, J., JENNINGS, L. K., CAZENAVE, J. P. et LANZA, F., 1994. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood [en ligne]. 1994. Vol. 84, n° 4pp. 1108-1115. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=80494271. 308.
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment
OSSELAER, J. C., CAZENAVE, J. P., LAMBERMONT, M., GARRAUD, O., HIDAJAT, M., BARBOLLA, L., TARDIVEL, R., DEFOIN, L., WALLER, C., MENDEL, I., RAIDOT, J. P., KANDEL, G., DE MEUTER, R., FABRIGLI, P., DEHENAU, D., ARROYO, J. L., PADRON, F., GOUEZEC, H., CORRAL, M., JACQUET, M., SUNDIN, D., LIN, L. et CORASH, L., 2008. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment. Vox Sanguinis [en ligne]. 2008. Vol. 94, pp. 315-323. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18248574
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment
CAZENAVE, J. P., WALLER, C., KIENTZ, D., MENDEL, I., LIN, L., JACQUET, M., PROPST, M., LIU, W., CORASH, L., SUNDIN, D., DEFOIN, L., MESSE, N. et OSSELAER, J. C., 2010. An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment. Transfusion. 2010. Vol. 50, pp. 1210-1219.
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
ZIMMER, J., DONATO, L., HANAU, D., CAZENAVE, J. P., TONGIO, M. M., MORETTA, A. et DE LA SALLE, H., 1998. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). Journal of Experimental Medcine [en ligne]. 1998. Vol. 187, n° 1pp. 117-122. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=94192171. 389.
Actualités en transfusion sur la conservation des plaquettes.
CAZENAVE, J. P., ISOLA, H., GACHET, C. et ALEIL, B., 2005. Actualités en transfusion sur la conservation des plaquettes. Transfusion Clinique et Biologique [en ligne]. 2005. Vol. 12, n° 2pp. 226-229. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=159508931. 519.
[Adaptation of platelet concentrates delivery to HAS/ANSM requirements evolution in EFS Grand-Est] = Adaptation de la delivrance des concentres plaquettaires aux recommandations HAS/ANSM 2015 a l'EFS Grand-Est.
KIENTZ, D., HUMBRECHT, C., ISOLA, H. et GACHET, Christian, 2018. [Adaptation of platelet concentrates delivery to HAS/ANSM requirements evolution in EFS Grand-Est] = Adaptation de la delivrance des concentres plaquettaires aux recommandations HAS/ANSM 2015 a l'EFS Grand-Est. Transfusion clinique et biologique. 2018. Vol. 25, n° 3pp. 187-191. DOI 10.1016/j.tracli.2018.06.006.
Adduct formation between soluble fibrin monomers and elastin.
RABAUD, M., LEFEBVRE, F., MARTIN, M. T., APRAHAMIAN, M., SCHMITTHAEUSLER, R. et CAZENAVE, J. P., 1987. Adduct formation between soluble fibrin monomers and elastin. Biomaterials [en ligne]. 1987. Vol. 8, n° 3pp. 217-222. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=28861581. 141.
Adenine triphosphate nucleotides are antagonists at the P2Y receptor
KAUFFENSTEIN, G., HECHLER, B., CAZENAVE, J. P. et GACHET, C., 2004. Adenine triphosphate nucleotides are antagonists at the P2Y receptor. Journal of Thrombosis and Haemostasis [en ligne]. 2004. Vol. 2, n° 11pp. 1980-1988. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15550030
Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets
CATTANEO, M., GACHET, C., CAZENAVE, J. P. et PACKHAM, M. A., 2002. Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets. Blood [en ligne]. 2002. Vol. 99, pp. 3868-3870;. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12014368
ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing
BENDER, M., ECKLY, A., HARTWIG, J. H., ELVERS, M., PLEINES, I., GUPTA, S., KROHNE, G., JEANCLOS, E., GOHLA, A., GURNIAK, C., GACHET, C., WITKE, W. et NIESWANDT, B., 2010. ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing. Blood. 2010. Vol. 116, pp. 1727-1775.
Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets.
ABECASSIS, Joseph, MILLON-COLLARD, R., KLEIN-SOYER, C., NICORA, F., FRICKER, J. P., BERETZ, Alain, EBER, M., MULLER, D. et CAZENAVE, Jean-pierre P., 1987. Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets. International Journal of Cancer [en ligne]. 1987. Vol. 40, n° 4pp. 525-531. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=36669901. 150.
Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells.
HAEGEL-KRONENBERGER, H., DE LA SALLE, H., BOHBOT, A., OBERLING, F., CAZENAVE, J. P. et HANAU, D., 1998. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. Journal of Immunology [en ligne]. 1998. Vol. 161, n° 8pp. 3902-3911. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=97801561. 404.
ADP induced blood platelet activation: a review.
GACHET, C. et CAZENAVE, J. P., 1991. ADP induced blood platelet activation: a review. Nouvelle Revue Française d'Hématologie [en ligne]. 1991. Vol. 33, n° 5pp. 347-358. [Consultésans date]. Consulté de : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18033251. 249.

Pages

Islandora displays